Gut decisions based on the liver: prediction of colorectal neoplasia using AI-based liver analysis of routine CT scans - Report - MDSpire

Gut decisions based on the liver: prediction of colorectal neoplasia using AI-based liver analysis of routine CT scans

  • By

  • Anna Hinterberger

  • Jonas Bohn

  • Darya Trofimova

  • Nicolas Knabe

  • Julia Dettling

  • Tobias Norajitra

  • Fabian Isensee

  • Johannes Betge

  • Stefan O. Schönberg

  • Dominik Nörenberg

  • Sergio Grosu

  • Sonja Loges

  • Ralf Floca

  • Jakob Nikolas Kather

  • Klaus Maier-Hein

  • Freba Grawe

  • June 3, 2026

  • 0 min

Share

Clinical Report: Leveraging Liver Analysis for Colorectal Neoplasia Prediction

Overview

This study evaluates the use of AI-based liver analysis from routine CT scans to predict colorectal neoplasia, demonstrating a significant potential for opportunistic screening. The best-performing model achieved an AUROC of 0.810, indicating promising accuracy in identifying colorectal neoplasia.

Background

Colorectal cancer (CRC) is a leading cause of cancer-related mortality, with low screening participation rates contributing to its prevalence. Non-invasive screening methods are crucial for increasing participation and reducing mortality. This study explores the gut-liver axis as a novel biomarker source for CRC risk prediction, leveraging existing CT imaging data.

Data Highlights

ModelAUROCSensitivitySpecificity
XGBoost0.81074.1%72.3%
Clinical-only model0.457N/AN/A
Subclassification (CRC vs. adenoma)0.674N/AN/A

Key Findings

  • AI-based liver analysis can predict colorectal neoplasia using routine CT scans.
  • The XGBoost model achieved an AUROC of 0.810, significantly outperforming clinical-only models.
  • Sensitivity and specificity for detecting colorectal neoplasia were 74.1% and 72.3%, respectively.
  • Subclassification between CRC and adenoma showed lower accuracy with an AUROC of 0.674.
  • This approach utilizes existing CT scans, potentially increasing screening participation without additional burden.

Clinical Implications

The findings suggest that integrating AI-based liver analysis into routine practice could enhance colorectal neoplasia screening efforts. Clinicians may consider leveraging existing CT imaging data to identify patients at risk for CRC, thereby facilitating earlier intervention.

Conclusion

AI-driven analysis of liver features from routine CT scans presents a promising adjunct to traditional colorectal cancer screening methods. This approach could significantly improve early detection and risk stratification in clinical settings.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Leveraging deep learning and explainable AI for effective liver tumor classification from CT scan images
  2. The ASCO Post, 2026 -- AI Model May Predict Cancer Risk in Patients With Colitis-Associated Low-Grade Dysplasia
  3. European Radiology, 2024 -- Creation and assessment of a radiopathomics model for forecasting liver metastases in colorectal cancer patients
  4. Press Releases, 2026 -- Colorectal cancer screening guideline update
  5. the asco post — AI Model May Predict Cancer Risk in Patients With Colitis-Associated Low-Grade Dysplasia
  6. Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial
  7. The association between metabolic-associated fatty liver diseases and risk of colorectal polyps, neoplasia, and cancer: A systematic review and meta-analysis
  8. Press Releases

Original Source(s)

Related Content